image credit: Freepik

What to watch at next week’s FDA meeting on COVID-19 vaccines for kids

October 22, 2021


A group of advisers to the Food and Drug Administration will meet Tuesday to discuss one of the most important questions since coronavirus vaccines first became available last year: whether to make them available to young children.

Their recommendation could pave the way for the roughly 28 million Americans between 5 and 11 years old to receive Pfizer and BioNTech’s vaccine, a potential turning point in the pandemic. A positive outcome is anticipated by the Biden administration, which, as with booster shots earlier this summer, detailed its rollout plans before drug regulators made their decision.

Read More on Biopharma Dive